Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iterum Therapeutics (ITRM) Treasury Shares (2017 - 2022)

Historic Treasury Shares for Iterum Therapeutics (ITRM) over the last 6 years, with Q3 2022 value amounting to $128096.0.

  • Iterum Therapeutics' Treasury Shares fell 9003.4% to $128096.0 in Q3 2022 from the same period last year, while for Sep 2022 it was $128096.0, marking a year-over-year decrease of 9003.4%. This contributed to the annual value of $119017.0 for FY2021, which is 8163.05% up from last year.
  • Latest data reveals that Iterum Therapeutics reported Treasury Shares of $128096.0 as of Q3 2022, which was down 9003.4% from $1.9 million recorded in Q2 2022.
  • In the past 5 years, Iterum Therapeutics' Treasury Shares registered a high of $1.9 million during Q2 2022, and its lowest value of $2090.0 during Q4 2019.
  • Its 5-year average for Treasury Shares is $665344.6, with a median of $585048.0 in 2020.
  • As far as peak fluctuations go, Iterum Therapeutics' Treasury Shares plummeted by 9433.97% in 2019, and later soared by 322196.26% in 2020.
  • Iterum Therapeutics' Treasury Shares (Quarter) stood at $36924.0 in 2018, then tumbled by 94.34% to $2090.0 in 2019, then surged by 3035.26% to $65527.0 in 2020, then soared by 81.63% to $119017.0 in 2021, then rose by 7.63% to $128096.0 in 2022.
  • Its Treasury Shares was $128096.0 in Q3 2022, compared to $1.9 million in Q2 2022 and $1.2 million in Q1 2022.